Molecular Analysis Refines Diagnosis, Enables Personalized Treatment for Pediatric CNS Tumors
Of the patients who completed follow-up, 60% had a targeted therapy recommendation.
CNS Cancers
Larotrectinib Produces “Remarkable” Responses in NTRK Fusion-Positive CNS Tumors
The median duration of response was not reached at a median follow-up of 26 months.
Proton Therapy vs IMRT: Similar Risk of Secondary Neoplasms in CNS Tumor Survivors
There was no significant difference in rates of secondary neoplasms at 10 years.
Health Care Providers Lack Knowledge About Pediatric CNS Tumors, Survey Suggests
A global survey of health care providers revealed significant knowledge gaps about childhood central nervous system tumors.
Blood Biomarkers May Help ID Primary CNS Lymphoma, High-Grade Glioma
Systemic inflammatory biomarkers may be useful in the differential diagnosis of primary central nervous system lymphoma and high-grade glioma.
Maternal Hormonal Contraception, CNS Tumors Not Linked in Children
No significant association was seen between maternal hormonal contraception use and CNS tumors in children younger than 20 years.
2008 to 2017 Saw Drop in Malignant Brain Tumor Incidence
Incidence rates decreased overall but increased among children and adolescents.
Medicinal Cannabis Improves Quality of Life for Patients With High-Grade Gliomas
A 1:1 ratio of THC to CBD proved superior to a 4:1 ratio.
Carboplatin Intensification Beneficial for Group 3 Medulloblastoma
Therapy intensification with carboplatin improved five-year event-free survival in children with high-risk group 3 medulloblastoma only.
Very Elderly Can Benefit From Brain Tumor Surgery
While there is short-term excess mortality, cumulative survival is similar to the general population.
- Loading...
Loading...
Next post in Brain Cancer
Loading... 
Loading...